FDA finds a wave of products marketed as supplements but spiked with drug ingredients through an “examination of international mail shipments” in enforcement likely targeting commercial imports in personal packages.
Most of the products identified in 26 public notifications published between Feb
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?